Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

AdcendoAnnounceChange

More Like This

PR Newswire associated0

Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline

PR Newswire associated0

Adcendo ApS to Participate in Upcoming September Investor Conferences

PR Newswire associated0

Adcendo ApS to Present Data on its Clinical Stage ADCs ADCE-T02 and ADCE-D01 at the 2025 American Association for Cancer Research (AACR) Annual Meeting

PR Newswire associated0

Adcendo ApS Announces First Patient Dosed in Phase I/II ADCElerate1 Trial of ADCE-D01

Business Wire logo

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

PR Newswire associated0

Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02

PR Newswire associated0

Adcendo ApS Announces FDA Fast Track Designation Granted to ADCE-D01 for the Treatment of Soft Tissue Sarcoma

PR Newswire associated0

Prescient Healthcare Group Announces the Appointment of Two New Members to Its Board of Directors